Department of Biochemistry and Molecular Biology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, United States; The Affiliated Hospital of Qingdao University & The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, Qingdao, China
Di Lang
Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, United States; Department of Medicine, University of California, San Francisco, San Francisco, United States
Jianhua Yan
Department of Biochemistry and Molecular Biology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, United States; Division of Cardiology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School Of Medicine, Shanghai, China
Haisong Bu
Department of Biochemistry and Molecular Biology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, United States; Department of Cardiothoracic Surgery, Xiangya Hospital, Central South University, Changsha, China
Hongsong Li
Department of Biochemistry and Molecular Biology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, United States; Department of Cardiovascular Medicine, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Science, Shanghai, China
Kunli Jiao
Department of Biochemistry and Molecular Biology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, United States; Division of Cardiology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School Of Medicine, Shanghai, China
Jingchun Yang
Department of Biochemistry and Molecular Biology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, United States
Haibo Ni
Department of Pharmacology, University of California, Davis, Davis, United States
Stefano Morotti
Department of Pharmacology, University of California, Davis, Davis, United States
Tai Le
Department of Biomedical Engineering, University of California, Irvine, Irvine, United States
Department of Biochemistry and Molecular Biology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, United States
Hung Cao
Department of Biomedical Engineering, University of California, Irvine, Irvine, United States; Department of Electrical Engineering and Computer Science, University of California, Irvine, Irvine, United States
Yuji Zhang
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, United States
Jun Wang
Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, United States
Eleonora Grandi
Department of Pharmacology, University of California, Davis, Davis, United States
Zhiqiang Li
The Affiliated Hospital of Qingdao University & The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, Qingdao, China
Yongyong Shi
The Affiliated Hospital of Qingdao University & The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, Qingdao, China
Yigang Li
Division of Cardiology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School Of Medicine, Shanghai, China
Alexey V Glukhov
Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, United States
Previously we showed the generation of a protein trap library made with the gene-break transposon (GBT) in zebrafish (Danio rerio) that could be used to facilitate novel functional genome annotation towards understanding molecular underpinnings of human diseases (Ichino et al, 2020). Here, we report a significant application of this library for discovering essential genes for heart rhythm disorders such as sick sinus syndrome (SSS). SSS is a group of heart rhythm disorders caused by malfunction of the sinus node, the heart’s primary pacemaker. Partially owing to its aging-associated phenotypic manifestation and low expressivity, molecular mechanisms of SSS remain difficult to decipher. From 609 GBT lines screened, we generated a collection of 35 zebrafish insertional cardiac (ZIC) mutants in which each mutant traps a gene with cardiac expression. We further employed electrocardiographic measurements to screen these 35 ZIC lines and identified three GBT mutants with SSS-like phenotypes. More detailed functional studies on one of the arrhythmogenic mutants, GBT411, in both zebrafish and mouse models unveiled Dnajb6 as a novel SSS causative gene with a unique expression pattern within the subpopulation of sinus node pacemaker cells that partially overlaps with the expression of hyperpolarization activated cyclic nucleotide gated channel 4 (HCN4), supporting heterogeneity of the cardiac pacemaker cells.